Abram Becker is an Innovation and Commercialization Specialist at Discovery to Product, where he helps move life science and healthcare innovations to market. Abram has over 20 years of diverse strategic, operational, and financial experience gained from roles working with start-ups, non-profits, and industry-leading multinational corporations including Bristol-Myers Squibb, UBS and Ipsos. As Vice President of Commercial Strategy at Ipsos, a global market research and consulting firm, he worked with teams around the world to help pharmaceutical, biotech, medical device, and diagnostic companies make data-driven product development and commercial strategy decisions. Prior to Ipsos, Abram worked in healthcare equity research as a member of an Institutional Investor ranked analyst team at UBS Investment Bank. He joined UBS from Bristol-Myers Squibb, where his global and U.S. roles included responsibility for managing global market research and business intelligence for a $5 billion pharmaceutical product. Abram also has experience as an early employee, founding team member, consultant, and advisor to start-ups and early stage companies. Abram graduated with honors from Duke University with a BS in Biology and later received an MBA with a Certificate in Health Sector Management from The Fuqua School of Business at Duke.